$20.22
2.02% yesterday
Nasdaq, Jun 02, 10:00 pm CET
ISIN
US8753722037
Symbol
TNDM

Tandem Diabetes Care, Inc. Target price 2025 - Analyst rating & recommendation

Tandem Diabetes Care, Inc. Classifications & Recommendation:

Buy
46%
Hold
50%
Sell
4%

Tandem Diabetes Care, Inc. Price Target

Target Price $35.85
Price $20.22
Potential
Number of Estimates 20
20 Analysts have issued a price target Tandem Diabetes Care, Inc. 2026 . The average Tandem Diabetes Care, Inc. target price is $35.85. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 24 analysts: 11 Analysts recommend Tandem Diabetes Care, Inc. to buy, 12 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Tandem Diabetes Care, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Tandem Diabetes Care, Inc. stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 940.20 1,004.01
25.74% 6.79%
EBITDA Margin -8.78% 3.13%
52.71% 135.66%
Net Margin -10.21% -13.47%
65.69% 31.88%

21 Analysts have issued a sales forecast Tandem Diabetes Care, Inc. 2025 . The average Tandem Diabetes Care, Inc. sales estimate is

$1.0b
Unlock
. This is
2.14% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.0b 4.38%
Unlock
, the lowest is
$998m 1.50%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $940m 25.74%
2025
$1.0b 6.79%
Unlock
2026
$1.1b 11.14%
Unlock
2027
$1.2b 9.84%
Unlock
2028
$1.4b 10.29%
Unlock
2029
$1.4b 6.01%
Unlock

18 Analysts have issued an Tandem Diabetes Care, Inc. EBITDA forecast 2025. The average Tandem Diabetes Care, Inc. EBITDA estimate is

$31.5m
Unlock
. This is
141.90% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$42.3m 156.29%
Unlock
, the lowest is
$24.2m 132.24%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-82.5m 40.53%
2025
$31.5m 138.12%
Unlock
2026
$70.3m 123.46%
Unlock
2027
$123m 74.55%
Unlock
2028
$196m 59.96%
Unlock
2029
$203m 3.33%
Unlock

EBITDA Margin

2024 -8.78% 52.71%
2025
3.13% 135.66%
Unlock
2026
6.30% 101.28%
Unlock
2027
10.01% 58.89%
Unlock
2028
14.52% 45.05%
Unlock
2029
14.15% 2.55%
Unlock

16 Tandem Diabetes Care, Inc. Analysts have issued a net profit forecast 2025. The average Tandem Diabetes Care, Inc. net profit estimate is

$-135m
Unlock
. This is
26.44% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-67.2m 63.43%
Unlock
, the lowest is
$-189m 2.82%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-96.0m 56.86%
2025
$-135m 40.85%
Unlock
2026
$-42.1m 68.88%
Unlock
2027
$1.5m 103.49%
Unlock
2028
$53.2m 3,516.33%
Unlock
2029
$51.9m 2.33%
Unlock

Net Margin

2024 -10.21% 65.69%
2025
-13.47% 31.88%
Unlock
2026
-3.77% 72.01%
Unlock
2027
0.12% 103.18%
Unlock
2028
3.93% 3,175.00%
Unlock
2029
3.62% 7.89%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.47 -2.03
57.14% 38.10%
P/E negative
EV/Sales 1.33

16 Analysts have issued a Tandem Diabetes Care, Inc. forecast for earnings per share. The average Tandem Diabetes Care, Inc. EPS is

$-2.03
Unlock
. This is
26.98% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.01 63.67%
Unlock
, the lowest is
$-2.84 2.16%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.47 57.14%
2025
$-2.03 38.10%
Unlock
2026
$-0.63 68.97%
Unlock
2027
$0.02 103.17%
Unlock
2028
$0.80 3,900.00%
Unlock
2029
$0.78 2.50%
Unlock

P/E ratio

Current -7.27 69.19%
2025
-9.95 36.80%
Unlock
2026
-31.98 221.41%
Unlock
2027
915.35 2,962.26%
Unlock
2028
25.32 97.23%
Unlock
2029
25.92 2.37%
Unlock

Based on analysts' sales estimates for 2025, the Tandem Diabetes Care, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.36 67.15%
2025
1.33 2.41%
Unlock
2026
1.19 10.02%
Unlock
2027
1.09 8.96%
Unlock
2028
0.99 9.33%
Unlock
2029
0.93 5.67%
Unlock

P/S ratio

Current 1.37 68.12%
2025
1.34 2.10%
Unlock
2026
1.21 10.02%
Unlock
2027
1.10 8.96%
Unlock
2028
1.00 9.33%
Unlock
2029
0.94 5.67%
Unlock

Current Tandem Diabetes Care, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citigroup
Locked
Locked
Locked May 22 2025
Wells Fargo
Locked
Locked
Locked May 01 2025
Baird
Locked
Locked
Locked May 01 2025
Piper Sandler
Locked
Locked
Locked May 01 2025
Canaccord Genuity
Locked
Locked
Locked May 01 2025
Stifel
Locked
Locked
Locked May 01 2025
Mizuho
Locked
Locked
Locked Apr 10 2025
Analyst Rating Date
Locked
Citigroup:
Locked
Locked
May 22 2025
Locked
Wells Fargo:
Locked
Locked
May 01 2025
Locked
Baird:
Locked
Locked
May 01 2025
Locked
Piper Sandler:
Locked
Locked
May 01 2025
Locked
Canaccord Genuity:
Locked
Locked
May 01 2025
Locked
Stifel:
Locked
Locked
May 01 2025
Locked
Mizuho:
Locked
Locked
Apr 10 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today